Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share, nominal value 0.01 per share
-
Shares outstanding
-
49,938,272
-
Total 13F shares
-
14,210,499
-
Share change
-
+1,783,553
-
Total reported value
-
$591,072,741
-
Put/Call ratio
-
7.2%
-
Price per share
-
$41.59
-
Number of holders
-
67
-
Value change
-
+$80,484,868
-
Number of buys
-
35
-
Number of sells
-
30
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 per share (BCYC) as of Q3 2021
As of 30 Sep 2021,
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 per share (BCYC) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,210,499 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, JANUS HENDERSON GROUP PLC, Point72 Asset Management, L.P., Logos Global Management LP, SV Health Investors, LLC, EVENTIDE ASSET MANAGEMENT, LLC, First Light Asset Management, LLC, Ikarian Capital, LLC, FMR LLC, and SAMLYN CAPITAL, LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.